Table 5.
Direction of outcome for each predictor performance measure
| Predictor at enrolment | 18-month outcome |
|---|---|
| Higher number of active joints | Worse |
| Higher number of effused joints | Worse |
| TMJ involvement | Worse |
| Wrist involvement | Worse |
| Knee involvement | Better |
| Ankle involvement | Better |
| Older age | Worse |
| Male | Better |
| Female | Worse |
| ANA positivity | Better |
| High ESR | Worse |
| Higher levels of IL-10 | Better |
| Higher levels of IL-12p70 | Worse |
| Higher levels of IL-17 | Worse |
| Higher levels of vitamin D | Better |
| Higher levels of sLRP1 | Better |
sLRP1: soluble low-density lipoprotein receptor-related protein 1; TMJ: temporomandibular joint.